Corticobasal Syndrome
13
7
8
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (13)
Digital Measurements of Motor and Voice Functions in FTD
Music and Brain Stimulation for Upper Extremity Performance in Patients With Corticobasal Syndrome
The CurePSP Genetics Program
Scrambler Therapy for Corticobasal Syndrome-Associated Pain
Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling
STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
Imaging Studies in Corticobasal Syndrome
Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer's Disease
Diagnosing Frontotemporal Lobar Degeneration
The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism
In-Home Care for Patients With PSP and Related Disorders
Rho Kinase (ROCK) Inhibitor in Tauopathies - 1
Electrical Polarization of the Brain in Corticobasal Syndrome